Literature DB >> 28609372

Pancreatic Polypeptide Cell Proliferation in the Pancreas and Duodenum Coexisting in a Patient With Pancreatic Adenocarcinoma Treated With a GLP-1 Analog.

Geoffrey A Talmon1, J David Wren, Christophe L Nguyen, Parviz M Pour.   

Abstract

A partial pancreaticogastrodudenectomy was performed on a 66-year old man with type 2 diabetes mellitus because of an invasive, moderately differentiated adenocarcinoma in the head of the pancreas. In the adjacent grossly normal tissue of the uncinate process, there was a massive proliferation of pancreatic polypeptide (PP) cells confined to this region and showed invasive pattern. Strikingly, in the heaped area of his duodenum, there was a strikingly large number of PP, glucagon, a few insulin cells in a mini-islet-like patterns composed of glucagon and insulin cells. Among the etiological factors, the possible long-lasting effects of the GLP-1 analog, with which the patient was treated, are discussed. This is the first report in the literature of both the coexistence of a pancreatic adenocarcinoma and invasive PPoma and the occurrence of PP and insulin cells in human duodenal mucosa.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28609372     DOI: 10.1097/MPA.0000000000000844

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  3 in total

Review 1.  PPoma Review: Epidemiology, Aetiopathogenesis, Prognosis and Treatment.

Authors:  Thais Ligiero Braga; Ralph Santos-Oliveira
Journal:  Diseases       Date:  2018-01-11

2.  A Diabetic Patient Complicated With Pancreatic Cancer After Using Liraglutide: A Case Report.

Authors:  Shengjie Wu; Jiabing Wang; Li Jing; Liping Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-28       Impact factor: 5.555

3.  Prevention of pancreatic acinar cell carcinoma by Roux-en-Y Gastric Bypass Surgery.

Authors:  Rui He; Yue Yin; Wenzhen Yin; Yin Li; Jing Zhao; Weizhen Zhang
Journal:  Nat Commun       Date:  2018-10-10       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.